International Stem Cell Corporation Common Stock

YTD

ALL

Why Robinhood?

You can watch ISCO and buy or sell other stocks, ETFs, and their options commission-free!

About ISCO

International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases.

CEO

Andrey Semechkin

CEOAndrey Semechkin

Employees

Employees32

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2005

Founded2005

Employees

Employees32

ISCO Key Statistics

Market cap

880.48K

Market cap880.48K

Price-Earnings ratio

-2.86

Price-Earnings ratio-2.86

Dividend yield

—

Dividend yield—

Average volume

196.90

Average volume196.90

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.195

52 Week high$0.195

52 Week low

$0.0521

52 Week low$0.0521

International Stem Cell Corporation Common Stock

Why Robinhood?

International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases. Show more

ISCO Key Statistics

International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases.